Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

REP 2139-Mg: Preliminary Ph II REP 401 data

February 3, 2017 5:35 PM UTC

Preliminary data from 40 treatment-naïve, non-cirrhotic patients with HBeAg-negative chronic HBV infection in the open-label Phase II REP 401 trial showed that once-weekly 250 mg IV REP 2139-Mg and RE...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Replicor Inc.